Skip To Content
 

Search:

 

Diagnostic Imaging Pathways - Suspected Mediastinal Mass
PathwaysHome
Flow Chart
Image gallery
Teaching Points
References
PDF Version

References

  1. Moore EH. Radiologic evaluation of mediastinal masses. Chest Surgery Clinics of North America 1992;2(1):1-22.
  2. Wright CD, Mathisen DJ. Mediastinal tumors: diagnosis and treatment. World J Surg 2001;25:204-9.
  3. Feigin DS, Padua EM. Mediastinal masses: a system for diagnosis based on computed tomography. CT 1986;10:11-21.
  4. Gamsu G, Stark DD, Webb WR, et al. Magnetic resonance imaging of benign mediastinal masses. Radiology 1984;151:709-13. (Level IV evidence)
  5. Levitt RG, Glazer HS, Roper CL, et al. Magnetic resonance imaging of mediastinal and hilar masses: comparison with CT. AJR 1985;145:9-14. (Level III evidence)
  6. Erasmus JJ, McAdams HP, Donnelly LF, et al. MR imaging of mediastinal masses. MRI Clin North America 2000;8(1):59-89.
  7. Von Schulthess GK, McMurdo K, Tscholakoff D, et al. Mediastinal masses: MR imaging. Radiology 1986;158:289-96. (Level III evidence)
  8. Gupta N, Gill H, Graeber G, Bishop H, Hurst J, Stephens T. Dynamic Positron Emission Tomography With F-18 Fluorodeoxyglucose Imaging in Differentiation of Benign From Malignant Lung/Mediastinal Lesions. Chest 1998;114:1105-11. (Level III evidence)
  9. Bangerter M, Kotzerke J, Griesshammer M, Elsner K, Reske SN, Bergmann L. Positron Emission Tomography with 18-Fluorodeoxyglucose in the Staging and Follow-up of Lymphoma in the Chest. Acta Oncologica 1999;38:799-804. (Level III evidence)
  10. Strollo DC, Rosado-de-Christenson ML, Jett JR. Primary mediastinal tumours: part II. Tumours of the middle and posterior mediastinum. Chest 1997;112:1344-57.
  11. Laurent F, Latrabe V, Lecesne R, Zennaro H, Airaud JY, Rauturier JF, Drouillard J. Mediastinal masses: diagnostic approach. European Radiology 1998;8:1148-59.
  12. American College of Radiology. ACR Appropriateness Criteria: Biopsies of Thoracic Nodules and Masses [document on the Internet]. 1996 [updated 2011]. (Review). Available from: http://www.acr.org/
  13. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA; American College of Chest Physicians. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007 Sep;132(3 Suppl):202S-220S. (Guidelines).
  14. Puli SR, Batapati Krishna Reddy J, Bechtold ML, Ibdah JA, Antillon D, Singh S, Olyaee M, Antillon MR. Endoscopic ultrasound: it's accuracy in evaluating mediastinal lymphadenopathy? A meta-analysis and systematic review. World J Gastroenterol. 2008 May 21;14(19):3028-37. (Level II evidence).
  15. Hirdes MM, Schwartz MP, Tytgat KM, Schlösser NJ, Sie-Go DM, Brink MA, et al. Performance of EUS-FNA for mediastinal lymphadenopathy: impact on patient management and costs in low-volume EUS centers. Surg Endosc. 2010 Sep;24(9):2260-7. (Level III evidence).
  16. Sheski FD, Mathur PN. Endobronchial ultrasound. Chest. 2008 Jan;133(1):264-70. (Review).
  17. Yasufuku K, Nakajima T, Fujiwara T, Yoshino I, Keshavjee S. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in the diagnosis of mediastinal masses of unknown etiology. Ann Thorac Surg. 2011 Mar;91(3):831-6. (Level III evidence).

Further Reading

  1. Kim Y, Lee KS, Yoo JH, et al. Middle mediastinal lesions: imaging findings and pathologic correlation. Eur J Radiol 2000;35:30-8.

File Formats

Some documents for download on this website are in a Portable Document Format (PDF). To read these files you may need to download Adobe® Acrobat Reader.

GetReader

Legal Matters